The Importance of a Timely Second Dose of the 2021 COVID-19 mRNA Vaccine Depends on the Protection Afforded by a First Dose and Subsequent Risk of Anaphylaxis is a research paper published in The Journal of Allergy and Clinical Immunology In Practice (2021). On theSindex it has a DataRank of 0. It has been cited 7 times.
Scored on demand from live citation data
Linked data & code
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
NIAID NIH HHS
Grant: R21 AI139021
NHGRI NIH HHS
Grant: R01 HG010863
NIAID NIH HHS
Grant: U01 AI154659
NIGMS NIH HHS
Grant: P50 GM115305
NIAID NIH HHS
Grant: R01 AI152183
National Institutes of Health
Grant: 1R01AI152183-01
Immune-mediated adverse drug reactions to HIV and TB treatments in South Africa: predict, prevent and improve long-term outcomes (IMARI SA study)
National Institutes of Health
Grant: 1R01HG010863-01
Genetic risk and long-term outcomes associated with Drug-induced Stevens-Johnson syndrome and toxic epidermal necrolysis in survivors
National Institutes of Health
Grant: 5U01AI154659-04
NATIENS: A Phase III Randomized Double Blinded Study to Determine the Mechanisms and Optimal Management of Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis
National Institutes of Health
Grant: 5R21AI139021-02
Single Cell definition of pathogenic T cells in Drug-induced Stevens-Johnson-Syndrome/Toxic epidermal necrolysis
National Institutes of Health
Grant: 5P50GM115305-05
Improving Prediction of Drug Action
FWCI
0.43
Citation Percentile
0.6%
Citation Trend
Fields of Study
MeSH Terms
Keywords
Sustainable Development Goals